Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.

RAGE is a molecular determinant in inducing the hallmarks of cancer cachexia, and molecular targeting of RAGE might represent a therapeutic strategy to prevent or counteract the cachectic syndrome.